表紙:肺がん手術市場 - 現在の分析と予測:2021年~2027年
市場調査レポート
商品コード
1017618

肺がん手術市場 - 現在の分析と予測:2021年~2027年

Lung Cancer Surgery Market: Current Analysis and Forecast (2021-2027)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 98 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.57円
肺がん手術市場 - 現在の分析と予測:2021年~2027年
出版日: 2021年06月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 98 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

がんは、世界の死因の第2位であり、2020年には1,000万人が死亡しています。WHOによると、約6人に1人が、がんによる死亡です。2020年には、世界全体で1,930万件の新規の症例が報告されています。肺がんの有病率と発症率の上昇が、市場の成長を促進する要因です。

当レポートでは、世界の肺がん手術市場について調査分析し、市場考察、市場力学、主要企業などについて、体系的な情報を提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法または前提条件

第3章 市場の要約

第4章 エグゼクティブサマリー

第5章 肺がん手術業界の主要スタートアップ

第6章 COVID-19の影響

第7章 世界の肺がん手術市場の収益

第8章 市場考察:手術別

  • 開胸術
    • 肺葉切除
    • スリーブ切除
    • 部分切除
    • 肺全摘術
  • 低侵襲手術

第9章 市場考察:デバイス別

  • 手術用
  • 監視用
  • 内視鏡用

第10章 市場考察:地域別

  • 北米の肺がん手術市場
    • 米国
    • カナダ
    • その他の北米
  • 欧州の肺がん手術市場
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋地域の肺がん手術市場
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他のアジア太平洋地域
  • その他の地域の肺がん手術市場

第11章 肺がん手術の市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第12章 法規制の枠組み

第13章 需要側分析・供給側分析

第14章 バリューチェーン分析

第15章 肺がん手術市場の機会

第16章 肺がん手術市場の動向・考察

第17章 競合シナリオ

  • ポーターのファイブフォース分析

第18章 企業プロファイル

  • Medtronic PLC
  • Accuracy Incorporated
  • GE Healthcare
  • Johnson and Johnson
  • Olympus Corporation
  • Siemens Healthineers AG
  • Ethicon Inc.
  • KARL STORZ GmbH

第19章 免責事項

目次
Product Code: UMHE21274

Lung cancer is the lethal lung tumour portrayed by the uncontrolled growth of cells in the lung tissues. The interpretation of lung cancer is confirmed by biopsy, which is carried out using bronchoscopy or CT guidance. Lung cancer surgery is the surgical ablation of cancer tissue from the lung. The type of surgery depends upon the size of the tumour and its position within the lung

Cancer is the second-leading cause of death worldwide, accounting for 10 million deaths in 2020. As per WHO, about 1 in 6 deaths occur due to cancer. 19.3 million new cases were reported in 2020, globally. The increase in cancer incidence at a global scale also indicates an increasing trend for the prevalence of lung cancers worldwide. In this scenario characterized by a favourable funding environment and effective treatment options, the growing incidence and prevalence of cancer are expected to increase the number of patients opting for lung cancer surgery in the coming years. This, in turn, is expected to drive the growth of the market in the coming years

Lung cancer treatments are primarily divided into four broader categories; diagnosis/imaging, surgeries, pharmacological assistance, and indirect costs (like transportation, caregiver wages, lodging, secondary effects treatments, and lost wages/ incomes). These categories incur substantial spending from government/insurance providers and additional costs paid by the patient itself. The hefty costs for treating lung cancers have created a substantial burden on the governments globally and cancer patients. Considering these high costs, despite the presence of a large patient pool, a limited number of patients opt for surgical interventions to treat their condition. This is a major factor restraining market growth

Based on surgery types, the market is fragmented into thoracotomy and Minimally Invasive Surgeries. The thoracotomy segment generated revenue of USD XX billion in 2020. However, the minimally invasive surgeries segment is expected to grow at the highest during the forecast period owing to the growing adoption of minimally invasive techniques, and the increasing trend of robotic surgeries. Thoracotomy is further bifurcated to lobectomy, sleeve resection, segmentectomy, and pneumonectomy surgeries.

Based on the device type, the market is fragmented into surgical, monitoring, and endo-surgical devices. The surgical devices segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027). The rising prevalence & incidence of lung cancer are the factors driving the market growth

For a better understanding of the market adoption of the Single Pair Ethernet market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for lung cancer surgery and generated revenue of USD XX billion in 2020 owing to the improved healthcare infrastructure and increase in healthcare spending

Some of the major players operating in the market include GE Healthcare, Johnson and Johnson, Olympus Corporation, Siemens Healthineers AG, Ethicon Inc., Medtronic Plc., KARL STORZ GmbH, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Lung Cancer Surgery Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Lung Cancer Surgery Market
    • 2.1.1 Main Objective of the Global Lung Cancer Surgery Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER LUNG CANCER SURGERY INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL LUNG CANCER SURGERY MARKET REVENUE

8 MARKET INSIGHTS BY SURGERY

  • 8.1 Thoracotomy
    • 8.1.1 Lobectomy
    • 8.1.2 Sleeve Resection
    • 8.1.3 Segmentectomy
    • 8.1.4 Pneumonectomy
  • 8.2 Minimally Invasive Surgery

9 MARKET INSIGHTS BY DEVICE

  • 9.1 Surgical Devices
  • 9.2 Monitoring Devices
  • 9.3 Endo-surgical Devices

10 MARKET INSIGHTS BY REGION

  • 10.1 NORTH AMERICA LUNG CANCER SURGERY MARKET
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Rest of North America
  • 10.2 EUROPE LUNG CANCER SURGERY MARKET
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 United Kingdom
    • 10.2.4 Spain
    • 10.2.5 Italy
    • 10.2.6 Rest of Europe
  • 10.3 ASIA PACIFIC LUNG CANCER SURGERY MARKET
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Australia
    • 10.3.5 Rest of Asia Pacific
  • 10.4 REST OF THE WORLD LUNG CANCER SURGERY MARKET

11 LUNG CANCER SURGERY MARKET DYNAMICS

  • 11.1 Market Drivers
  • 11.2 Market Challenges
  • 11.3 Impact Analysis

12 LEGAL & REGULATORY FRAMEWORK

13 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1 Demand Side Analysis
  • 14.2 Supply Side Analysis
    • 14.2.1 Top Product Launches
    • 14.2.2 Top Business Partnerships
    • 14.2.3 Top Merger & Acquisitions

14 VALUE CHAIN ANALYSIS

15 LUNG CANCER SURGERY MARKET OPPORTUNITIES

16 LUNG CANCER SURGERY MARKET TRENDS & INSIGHTS

17 COMPETITIVE SCENARIO

  • 17.1 Porter's Five forces analysis
    • 17.1.1 Bargaining power of Supplier
    • 17.1.2 Bargaining power of Buyer
    • 17.1.3 Industry Rivalry
    • 17.1.4 Availability of Substitute
    • 17.1.5 Threat of new Entrants

18 COMPANY PROFILED

  • 18.1 Medtronic PLC
  • 18.2 Accuracy Incorporated
  • 18.3 GE Healthcare
  • 18.4 Johnson and Johnson
  • 18.5 Olympus Corporation
  • 18.6 Siemens Healthineers AG
  • 18.7 Ethicon Inc.
  • 18.8 KARL STORZ GmbH

19 DISCLAIMER